# DoD Melanoma Mid-Career Accelerator Award

Source: https://welltoldgrants.com/grants/ht9425-23-mrp-mcaa-dod-melanoma-mid-career-accelerator-award/  
Official notice: https://www.grants.gov/search-results-detail/348201

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 3 awards worth $3.5 million in total. Applications closed on September 22, 2023.

| Field | Value |
|---|---|
| Opportunity number | HT9425-23-MRP-MCAA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 22, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 3 |
| Total funding | $3.5 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The MRP MCAA supports independent, mid-career investigators conducting impactful research in the field of melanoma. The MCAA presents an opportunity for mid-career investigators with prior experience in melanoma research and/or patient care to obtain funding to continue performing impactful research that will also accelerate their career and establish them as leaders in the melanoma field. Preliminary data relevant to melanoma are required. Key aspects of the MCAA: Principal Investigator: The Principal Investigator (PI) must be a mid-career researcher or physician-scientist at the level of Assistant or Associate Professor (or equivalent). The PI must be at least 7 years from obtaining their first faculty-level appointment. Instructors and full professors (or equivalents) are not eligible. The PI must demonstrate previous receipt of at least one peer-reviewed source of extramural funding. The PI’s record of accomplishments (publications, presentations, patents, etc.) and the proposed research will be evaluated regarding the PI’s potential for contributing to the melanoma field. Impact: The impact of the proposed research must relate to at least one of the FY23 MRP Focus Areas in Section II.A.1. Impactful research, including basic research, should expedite the advancement of promising ideas towards clinical utility. The application must articulate the short- and long-term impact the proposed work will have on melanoma research and/or patient care. Continuity Plan: The goal of the MCAA is to support investigators who have laid the foundation for becoming leaders in the melanoma field and who intend to advance the state of the science in melanoma. The Continuity Plan (Attachment 7) should explain how the PI has the potential to establish themselves as a leader in the melanoma field, beyond their own laboratory or institution. Additionally, it should describe the PI’s plan for the continued development of their research program to benefit melanoma research and/or patient care. Synergy with the MRP Melanoma Academy: To enhance networking and collaboration options for both the MCAA PI and MRP Melanoma Academy Scholars, MCAA PIs will be encouraged to participate in Melanoma Academy activities (e.g., networking events, seminars hosted by the MRP Melanoma Academy Leadership) as appropriate.

## Questions people ask

### Is HT9425-23-MRP-MCAA still open?

No. It closed on September 22, 2023. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Melanoma Mid-Career Accelerator Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Melanoma Mid-Career Accelerator Award?

Closed September 22, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $3.5 million in total across about 3 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.